Head and Neck Cancer
Conditions
Keywords
Head and neck cancer, Concurrent chemoradiotherapy, Progressive resistance training, Exercise, Feasibility, Weight loss, LBM, Body composition
Brief summary
The purpose of this study is to evaluate the feasibility of a 12-week progressive resistance training (PRT) during concurrent chemoradiotherapy in head and neck cancer patients compared to usual care.
Detailed description
12 patients with head and neck cancer will be recruited to this trial. Entering a 12-week PRT program which will start one week before radiotherapy. The tested training program is a 12-week, supervised, group based, progressive resistance training program involving the major muscle groups of the body. The program has previously been found to successfully restore the loss of lean body mass (LBM) in head and neck cancer patients post-treatment. A group based approach will be used to facilitate a social and motivating training environment for the patients. This approach has previously been used for exercise interventions for lung cancer patients at our facility, and was highly appreciated by the patients. In addition to baseline data (height, tumor stage, performance status, etc), the following parameters will be registered on a weekly basis: Weight, patient reported side effects, as well as a questionnaire on amount of physical activity and food intake. Physical function and strength will be tested at baseline, after the course of chemoradiotherapy and at the end of the 12-week PRT programme, and at 2, 5, 9 and 13 months follow-up. At similar time points dual energy x-ray absorptiometry (DXA) scans for body composition will be performed using a Lunar iDXA (GE Healthcare). Blood samples will be drawn at baseline, an additional three times during the first 6 weeks and then weekly in relation to training sessions, and at 2, 5, 9 and 13 months follow-up. Patient reported quality of life (EORTC Quality of Life Questionaire (QLQ)-C30 and QLQ-H&N35) will be registered at baseline, after 12-weeks PRT and during 5 and 13 months follow-up. Study duration is expected to be 7 months for the pilot-trial, with a follow-up of additional 13 months after the last patient has completed the intervention.
Interventions
BEHAVIORALProgressive resistance training
A 12-week, supervised, group based, progressive resistance training program involving the major muscle groups of the body will be tested. Details of the program: 12 weeks, 3 sessions per week, 7 exercises (leg press, leg curl, hamstring curl, chest press, lateral pull down, sit-ups and back extensions). In general 2-3 sets of 8-15 repetitions will be performed following a progression plan starting with more repetitions at lower intensity progressing to fewer repetitions at higher intensity during the 12-week period (American College of Sports Medicine Position Stand)
Sponsors
Herlev Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with head and neck squamous cell carcinoma * Candidates for concomitant chemoradiotherapy according to Danish Head and Neck Cancer Group (DAHANCA) guidelines. * Performance status 0-1 * Expected to be able to complete the intervention, i.e. no major comorbidities or social issues that could compromise attendance. * At least 18 years of age.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility | up to 7 months | The feasibility outcomes will be inclusion rate defined as the number of patients recruited from the number of eligible patients and completion rate defined as the number of participants able to complete the intervention. Adherence to the exercise intervention will be evaluated via patient-reported training logs. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in LBM | up to 20 months | Whole body LBM will be determined using dual energy x-ray absorptiometry (DXA). |
| Weight loss | up to 20 months | Patient will be weighed weekly during the 12-week PRT program; afterwards at each follow-up (2, 5, 9, and 13 months) |
| Number of patients with side-effects to treatment | up to 7 months | Side-effects will be registered using Common Terminology Criteria for Advers Events v4.0 (CTCAE). |
| Quality of Life | Up to 20 months | — |
| Change in physical function and strength | Up to 20 months | Change in muscle strength will be evaluated by 1 repetition maximum test (1RM) measured in kg. Change in muscle power will be evaluated by Nottingham Power Rig and measured in watts and watt/kg. Change in physical function will be evaluated by 30 second sit-to-stand test, arm curl test and stair climbing. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Muscle biopsies | up to 7 months | In order to establish energy-reserves in the muscles |
| Blood samples | Up to 20 months | In order to identify systemic factors released during exercise |
Countries
Denmark
Outcome results
None listed